14/15: Common Ulcerations and Case - Bennett Flashcards

1
Q

define ulcer

A
  • Lesion of the skin or mucous surface caused by superficial loss of tissue
  • Usually associated with necrosis and inflammation
  • Wound where the epidermis and part of the dermis is absent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Review Wagners Classification

A

Grade O – Intact skin (signs of inflammation, irritation, pre-ulcerative)

Grade I – Superficial (no sub Q involvement)

Grade II – Extends to tendon, capsule, bone (tracks)

Grade III – Associated with abscess, osteo, sepsis (clinical or radiographic signs of infection)

Grade IV – Gangrene of forefoot

Grade V – Gangrene of entire foot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Review UofT classification

A

Grade O – Intact Skin, Pre or post ulcerative site
Grade I – Ulcers are superficial wound through the epidermis/dermis
Grade II – Through tendon or capsule
Grade III – Through bone or into joints

Stage A – Clean
Stage B –Infection
Stage C – Ischemic
Stage D – Ischemic and infected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Review Knighton Classification

A

Grade I – Partial thickness (through epidermis)
Grade II – Full thickness (through dermis into sub Q)
Grade III – Full thickness (to tendon, ligament, bone, joint
Grade IV – Full thickness (associated abscess or osteo)
Grade V – Full thickness (necrosis)
Grade VI – Full thickness (ulcer with gangrene)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Review NPUAP classification

A

Stage I: Intact skin with non-blanchable redness of a localized area usually over a bony prominence. Darkly pigmented skin may not have visible blanching; its color may differ from the surrounding area

Stage II: Partial thickness loss of dermis presenting as a shallow open ulcer with a red pink wound bed, without slough. May also present as an intact or open/ruptured serum-filled blister.

Stage III: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon or muscle are not exposed. Slough may be present but does not obscure the depth of tissue loss. May include undermining and tunneling.

Stage IV: Full thickness tissue loss with exposed bone, tendon or muscle. Slough or eschar may be present on some parts of the wound bed. Often include undermining and tunneling.

Unstageable:Full thickness tissue loss in which the base of the ulcer is covered by slough (yellow, tan, gray, green or brown) and/or eschar (tan, brown or black) in the wound bed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

associated disease states for neuropathic ulcers (not just diabetes!)

A
Diabetes
Peripheral nerve injury
Alcoholism
Anemia
Tabes dorsalis
Chemotherapy/radiation treatment
Spina bifida
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

triad of diabetic ulcer

A
  1. neuropathy
  2. ischemia
  3. infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

etiology of diabetic ulcer

A
  • Insulin not required for glucose uptake in neurons
  • Therefore increased neuronal concentration in diabetics
  • This prevents myo-inositol by competitive inhibition
  • Low myo-inositol concentration in neurons results in abnormal cellular responses to receptor stimulation
  • Impaired Na/K ATPase activity and nerve dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glycation product, AGE’s cause …

A

Matrix overproduction
Focal thrombosis
Vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diabetics are at risk for developing repetitive injuries that do not heal well due to:

A

Ischemia
Painless
Low resistance to pathogenic organisms
– Attenuated inflammatory response, impaired chemotaxis, inefficient bacterial-killing
—Infection increases the local tissue metabolism, burdening a tenuous blood supply, amplifying tissue necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe a neuropathic wound

A
  • Absence of pain
  • Ischemia (macrovascular and/or microvascular) may or may not be present which will alter appearance of ulcer bed
  • Usually located in a weight bearing or pressure area
  • Well circumscribed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

clinical findings neuropathic ulcer

A
  • Underlying bone pathology (rocker bottom, metatarsal deformity, sesamoid, hammertoe)
  • Tissue is usually warm with a zone of hyperkeratotic tissue at the wound edges
  • No pain
  • Depth (depends on location, length of wound, infection)
  • Base of fibrous-granular tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

etiology venous ulceration

A
  • Prolonged venous hypertension
    • Incompetent valves
    • Superficial Thrombophlebitis
    • Deep vein thrombosis
    • Calf muscle dysfunction
  • Fibrin Cuff Hypothesis
  • White Cell Hypothesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe fibrin cuff hypothesis

A
  • Enlarged dermal capillaries, reduced capillary number, microvascular thrombosis, increased permeability of micro lymphatics
  • Increased capillary permeability leads to extravasation of plasma proteins like fibrinogen which forms an insoluble fibrin cuff
  • Fibrin cuff is a barrier to diffusion of oxygen and nutrients to overlying skin, therefore cell death and ulceration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe white cell hypothesis

A
  • Adhering leukocytes degranulate and release potent enzymes and reactive oxygen species that damage the capillaries and cause increased permeability and tissue damage
  • Macromolecules like albumin bind or trap growth factors and matrix material, therefore are unavailable for tissue maintenance or repair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe venous ulceration

A
  • Usually present with presence of arterial flow
  • Usually granulating bed (beefy red base)
  • Painful
  • Common by medial malleolus
  • Associated with venous insufficiency (edema, hemosiderin deposition, induration)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

describe varicose veins

A
  • Dilated, tortuous superficial veins
  • Increased deep venous pressure (venous hypertension)
  • Increased distensibility of the venous walls
  • Development of venous lakes [ blue, purple, compressible papules actually are dilated venules and capillaries ]
18
Q

describe thrombophlebitis

A
  • Great and lesser saphenous
  • Presents as pain, swelling, warmth (more localized)
  • Tender along the involved vein
  • Often confused with cellulitis and infection
  • Chronic recurrent bouts of inflammation along vein secondary to incompetent superficial veins
19
Q

how do varicose veins lead to an ulcer? (sequence of events)

A

Varicose veins –> Thrombophlebitis –> Deep venous thrombosis –> Inoperative muscle pump –> Development of eczematous plaque –> Tissue hypoxic –> Minor trauma –> Development of the ulceration

20
Q

clinical findings venous ulceration

A
Unilateral (medial ankle)
Stasis pigmentation
Chronic edema
Fibrous-granular base
Variable depth and size
****Irregular border (no hyperkeratotic rim)
Variable pain
Serous drainage (leakage)
21
Q

treatment venous ulcer

A
  • Culture and biopsy
  • Treatment of underlying infection with appropriate antibiotic therapy
  • Thorough exam (PADnet, etc)
    Elevation
  • Regular debridement of wound
  • control of inflammation
  • compression therapy
22
Q

key treatment venous wound

A

compression therapy

  • During wound care and often
  • Need a minimum of 30 mm Hg
  • Unnaboot @ 30 mmHg
  • Profore system @ 40 mmHg
23
Q

describe an arterial ulcer

A
Signs of diminished circulation
Usually painful *
Well circumscribed
Avascular wound bed
More fibrotic base
Any location on extremity, often where trauma has occurred
24
Q

etiology of arterial ulcers

A
Narrowing lumen
Can be worsened by a sudden thrombus (ischemic pain, blue toe, showering emboli)
Absent pedal pulses
Bruits
Temperature
Trophic skin changes
Muscle atrophy
Tissue necrosis
25
Q

describe diabetic microangiopathy and its association with arterial ulcers

A
  • Capillary basement membrane thickening
  • Increased blood viscosity
  • Increased platelet aggregation
  • Accelerated capillary endothelial cell aging
26
Q

describe an ischemic ulcer

A
  • Shallow with dark base, atrophic border.
  • Spontaneous ulcerations can start as a dark macule, then eschar, then necrosis.
  • Remember wound is over necrotic tissue (base) which will be soft (contaminated and infected)
27
Q

treatment ischemic ulcer

A
  • ** No sharp debribement
  • local wound care for light debridement: with guaze, wet to dry dressings
  • vascular consult
  • manage infection
28
Q

medial managment of ischemic ulcer

A
  • Avoidance of vasoconstriction (caffeine and nicotine)
  • Exercising to tolerance
  • Dependent position of extremities
  • Avoidance of tight socks and shoes
29
Q

etiology of pressure ulcers

A
  • Prolonged pressure on a bony prominence
  • Shear forces, friction, moisture
  • Deep tissue necrosis
  • Compression of capillary circulation
  • External pressure causes venous and lymphatic obstruction then arterial occlusion
  • Tissue ischemia leads to toxic metabolites which cause pain
  • Muscle and subcutaneous tissues are more susceptible to pressure-induced injury than is the epidermis
  • ie: deceptively minor skin defect with large zone of deep tissue necrosis
30
Q

describe a pressure ulcer

A
  • Wide ulcer with peripheral undermining
  • Preceded by intense erythema
  • Depth usually extends to subcutaneous tissue, close to underlying bone
  • Trouble areas: Sacrum, Heels
  • Due to repeated movement of the patient up and down in bed; friction and shearing
  • Underlying wound slow to heal
31
Q

what should you do to prevent a pressure ulcer?

A

Regular repositioning
Pressure relief beds and boots
Moisture barriers
*** Most preventable ulcer, should NOT occur

32
Q

describe vasculitis ulcers

A
  • Inflammatory vasculitis due to: Systemic lupus, Rheumatoid arthritis, Scleroderma, Sarcoidosis, Periarteritis nodosa
  • Elevated ESR, RF, ANA, lupus preparation, and cryoglobulinemia
  • Treat with prednisone!
33
Q

describe radiation ulcers

A
  • Follow radiation therapy for cancer
  • Ulcers get larger and deeper over time
  • Treat with full-thickness excision of radiation ulcer
34
Q

describe toxic drug ulcers

A
  • IV chemotherapy agents (5-FU or doxyrubicin)
  • Drugs of abuse
  • Treat with debridement, grafts and HBO therapy
35
Q

describe sickle cell ulcers

A
  • Hemozygous sickle cell anemia (Hbss)
  • Leg ulcers in 8-10%
  • Develop spontaneously or after trauma
  • Sickling of red cells leads to vascular obstruction, increased venous and capillary pressures, secondary infection, local tissue hypoxia
  • Very painful ulcers, can be over medial and lateral malleoli
  • Fibrosis, scarring, poor-granulation tissue
  • Recur frequently
36
Q

what are factitious ulcers?

A
  • Self-induced

- Treat the pysche and the wound

37
Q

describe a hypertensive ulcer

A
  • Reddish patch, becomes cyanotic, gray bed
  • Anterolateral leg, jx of lower and middle 1/3 of leg
  • Significant arterial HTN
  • Good pulses
  • Very painful
  • Irregular, ragged edges, necrotic, cyanotic borders, poor granulation tissue
  • Often symmetrical
38
Q

how do you treat hypertensive ulcer?

A

Ischemia secondary to obliterating small arterioles

  • ** Do NOT debride these ulcers!
  • Control their hypertension
  • Enhance tissue perfusion
  • Skin Graft
39
Q

describe a pyoderma gangernosum ulcer

A
  • Associated with ulcerative colitis
  • Starts as early pustule at a site of trauma
  • Turns rapidly to an ulcer
  • Purplish-blue undermined border
  • Base has honey-comb appearance
  • Severe pain associated with them
  • ** EXTENSIVE DEBRIDEMENT IS DETRIMENTAL
  • Treat with high dose systemic steroids
40
Q

5-FU and ulcers

A
  • causes toxic drug ulceration but also treatment for cancerous ulcerations
41
Q

what is marjolin’s ulcer?

A
  • no specific characteristics

- need to be biopsied for diagnosis (looking for transitional cells)